Stabilizing Cellular Barriers: Raising the Shields Against COVID-19

Area of Science:

• Cellular biology
• Virology
• Immunology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, a global health crisis.
• Disruption of epithelial and endothelial barriers is a critical factor in severe COVID-19 progression, leading to multi-organ dysfunction.
• Common COVID-19 risk factors like diabetes, obesity, and aging independently compromise barrier integrity, suggesting synergistic effects with SARS-CoV-2.

Purpose of the Study:

• To review the cellular mechanisms by which SARS-CoV-2 and risk factors disrupt barrier function.
• To explore potential therapeutic interventions for severe COVID-19 outcomes.

Main Methods:

• Literature review of cellular mechanisms involved in barrier disruption.
• Analysis of the interplay between SARS-CoV-2, risk factors, and barrier integrity.
• Exploration of potential therapeutic targets.

Main Results:

• SARS-CoV-2 and risk factors synergistically impair epithelial and endothelial barrier functions.
• These disruptions correlate with increased COVID-19 severity, respiratory distress, and multi-organ failure.
• Glucagon-like peptide 1 (GLP-1) signaling pathways are identified as potentially counteracting these detrimental effects.

Conclusions:

• Understanding barrier disruption mechanisms is crucial for managing severe COVID-19.
• GLP-1 signaling presents a promising therapeutic avenue to enhance barrier function and improve clinical outcomes in COVID-19 patients.
• Targeting barrier integrity could be a novel strategy to combat COVID-19 severity.